(Q36221953)

12 August 2017

1 reference

title

Potential therapeutic role of peroxisome proliferator activated receptor-gamma agonists in psoriasis (English)

1 reference

12 August 2017

Samir Malhotra

1

1 reference

12 August 2017

Dipika Bansal

2

1 reference

12 August 2017

Nusrat Shafiq

3

1 reference

12 August 2017

Promila Pandhi

4

1 reference

12 August 2017

Bhushan Kumar

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

9

1 reference

12 August 2017

page(s)

1455-1461

1 reference

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

The pathophysiology of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Mast cells in psoriatic skin are strongly positive for interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Neuropathogenesis and neuropharmacology of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Immunologic mechanisms in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

The pathogenesis of psoriasis: immunological facts and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

The immunology of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Orphan nuclear receptors: shifting endocrinology into reverse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Peroxisome proliferator-activated receptors in cutaneous biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Terminal differentiation of human breast cancer through PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Acitretin: optimal dosing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Peroxisome proliferator-activated receptors as new molecular targets in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1455

10.1517/14656566.6.9.1455

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference